HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Andrikopoulos Selected Research

Amyloid (Amyloid Fibrils)

6/2008Identification of the Alzheimer's disease amyloid precursor protein (APP) and its homologue APLP2 as essential modulators of glucose and insulin homeostasis and growth.
1/2003The effect of apolipoprotein E deficiency on islet amyloid deposition in human islet amyloid polypeptide transgenic mice.
12/2000beta-cell glucokinase deficiency and hyperglycemia are associated with reduced islet amyloid deposition in a mouse model of type 2 diabetes.
10/2000Oophorectomy promotes islet amyloid formation in a transgenic mouse model of Type II diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Andrikopoulos Research Topics

Disease

8Type 2 Diabetes Mellitus (MODY)
02/2016 - 10/2000
5Body Weight (Weight, Body)
02/2016 - 10/2000
5Obesity
03/2015 - 05/2002
4Insulin Resistance
07/2013 - 03/2003
3Weight Gain
02/2016 - 11/2007
2Glucose Intolerance
02/2016 - 03/2010
2Genetic Predisposition to Disease (Genetic Predisposition)
05/2011 - 06/2006
2Alzheimer Disease (Alzheimer's Disease)
06/2008 - 01/2003
1Myocardial Infarction
01/2020
1Peripheral Nervous System Diseases (PNS Diseases)
01/2020
1Peripheral Vascular Diseases (Peripheral Vascular Disease)
01/2020
1Diabetes Complications
01/2020
1Stroke (Strokes)
01/2020
1Erectile Dysfunction
01/2020
1Hypoglycemia (Reactive Hypoglycemia)
01/2020
1Weight Loss (Weight Reduction)
03/2015
1Fatty Liver
08/2014
1Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction)
08/2014
1Hypoxia (Hypoxemia)
01/2013
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
05/2011
1Disease Progression
12/2007
1Hypersensitivity (Allergy)
11/2007
1Hypertrophy
12/2003
1Amyloid Plaque
01/2003
1Amyloidosis
01/2003
1Hyperglycemia
12/2000

Drug/Important Bio-Agent (IBA)

10Glucose (Dextrose)FDA LinkGeneric
02/2016 - 10/2000
7Insulin (Novolin)FDA Link
07/2013 - 03/2003
4Amyloid (Amyloid Fibrils)IBA
06/2008 - 10/2000
2Proteins (Proteins, Gene)FDA Link
06/2008 - 03/2003
1CarbohydratesIBA
02/2016
1HDL CholesterolIBA
02/2016
1Blood Glucose (Blood Sugar)IBA
02/2016
1Triglycerides (Triacylglycerol)IBA
02/2016
1CholesterolIBA
08/2014
1Niacinamide (Nicotinamide)FDA LinkGeneric
01/2013
1TransferasesIBA
01/2013
1SirtuinsIBA
01/2013
1alagebriumIBA
05/2011
1ChloridesIBA
05/2011
1Receptor for Advanced Glycation End ProductsIBA
05/2011
1AutoantibodiesIBA
05/2011
11,3-di(4-imidazolinophenoxyl)propaneIBA
05/2011
1NADP TranshydrogenasesIBA
03/2010
1Peptides (Polypeptides)IBA
06/2008
1Amyloid beta-PeptidesIBA
06/2008
1Glyburide (Glibenclamide)FDA LinkGeneric
04/2008
1Transcription Factors (Transcription Factor)IBA
11/2007
1Neuropeptide YIBA
11/2007
1Melanins (Melanin)IBA
11/2007
1Pro-Opiomelanocortin (Proopiomelanocortin)IBA
11/2007
1alpha-MSHIBA
11/2007
1Hormones (Hormone)IBA
11/2007
1CytokinesIBA
11/2007
1Dietary Fats (Dietary Fat)IBA
11/2007
1LeptinIBA
11/2007
1Proprotein Convertase 1IBA
11/2007
1Proprotein Convertase 2IBA
11/2007
1PhosphoenolpyruvateIBA
10/2003
1Messenger RNA (mRNA)IBA
03/2003
1Interleukin-6 (Interleukin 6)IBA
03/2003
1ApolipoproteinsIBA
01/2003
1Apolipoproteins E (ApoE)IBA
01/2003
1Nonesterified Fatty Acids (NEFA)IBA
05/2002
1GlucokinaseIBA
12/2000

Therapy/Procedure

1Glycemic Control
01/2020
1Surgical Amputation (Amputations)
01/2020
1Carbohydrate-Restricted Diet (Low Carbohydrate Diet)
02/2016
1High-Protein Diet
03/2015